Kits Eyecare Ltd. (TSX: KITS)
Canada
· Delayed Price · Currency is CAD 9.00
+0.41 (4.77%)
Jul 19, 2024, 3:59 PM EDT
Kits Eyecare Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Revenue | 127.63 | 120.51 | 91.64 | 82.4 | 75.22 | 36.9 |
| Revenue Growth (YoY) | 28.58% | 31.51% | 11.21% | 9.55% | 103.86% | - |
| Cost of Revenue | 84.79 | 79.72 | 62.39 | 61.51 | 53.83 | 26.09 |
| Gross Profit | 42.84 | 40.79 | 29.25 | 20.89 | 21.39 | 10.81 |
| Selling, General & Admin | 41.77 | 40.09 | 33.65 | 34.67 | 19.44 | 7.2 |
| Depreciation & Amortization | 2.05 | 2.14 | 2.3 | 2.38 | 2.01 | 1.33 |
| Operating Expenses | 43.82 | 42.22 | 35.94 | 37.05 | 21.45 | 8.53 |
| Operating Income | -0.98 | -1.43 | -6.7 | -16.15 | -0.06 | 2.29 |
| Interest Expense | -1.49 | -1.56 | -1.63 | -1.49 | -2.22 | -1.86 |
| Interest & Investment Income | 0.59 | 0.59 | 0.11 | 0.07 | 0.01 | 0.01 |
| Net Interest Expenses | -0.91 | -0.98 | -1.52 | -1.42 | -2.21 | -1.85 |
| Currency Exchange Gain (Loss) | -0.09 | -0.95 | 2.34 | 0.71 | - | - |
| Other Non Operating Income (Expenses) | 0.46 | 0.47 | - | - | - | -0.11 |
| EBT Excluding Unusual Items | -1.52 | -2.89 | -5.88 | -16.86 | -2.27 | 0.33 |
| Merger & Restructuring Charges | - | - | - | - | -0.17 | -0.27 |
| Other Unusual Items | - | - | - | -1.98 | -4.65 | 0.02 |
| Pretax Income | -1.52 | -2.89 | -5.88 | -18.84 | -7.09 | 0.09 |
| Income Tax Expense | -0.38 | -0.68 | -1.32 | -4.23 | -0.51 | 0.04 |
| Net Income | -1.13 | -2.22 | -4.55 | -14.62 | -6.58 | 0.05 |
| Net Income to Common | -1.13 | -2.22 | -4.55 | -14.62 | -6.58 | 0.05 |
| Shares Outstanding (Basic) | 31 | 31 | 31 | 30 | 9 | 7 |
| Shares Outstanding (Diluted) | 31 | 31 | 31 | 30 | 9 | 7 |
| Shares Change (YoY) | 0.35% | 0.38% | 3.81% | 227.45% | 30.21% | - |
| EPS (Basic) | -0.04 | -0.07 | -0.15 | -0.49 | -0.72 | 0.01 |
| EPS (Diluted) | -0.04 | -0.07 | -0.15 | -0.49 | -0.72 | 0.01 |
| Free Cash Flow | 3.93 | 1.84 | 4.42 | -23.09 | 3.99 | 3.83 |
| Free Cash Flow Per Share | 0.13 | 0.06 | 0.14 | -0.77 | 0.43 | 0.54 |
| Gross Margin | 33.57% | 33.85% | 31.92% | 25.35% | 28.43% | 29.30% |
| Operating Margin | -0.77% | -1.19% | -7.31% | -19.60% | -0.08% | 6.20% |
| Profit Margin | -0.89% | -1.84% | -4.97% | -17.74% | -8.75% | 0.14% |
| Free Cash Flow Margin | 3.08% | 1.53% | 4.82% | -28.03% | 5.31% | 10.37% |
| EBITDA | 1.18 | 0.84 | -4.35 | -14.33 | 1.4 | 3.28 |
| EBITDA Margin | 0.92% | 0.70% | -4.74% | -17.39% | 1.87% | 8.89% |
| D&A For EBITDA | 2.16 | 2.28 | 2.35 | 1.83 | 1.46 | 0.99 |
| EBIT | -0.98 | -1.43 | -6.7 | -16.15 | -0.06 | 2.29 |
| EBIT Margin | -0.77% | -1.19% | -7.31% | -19.60% | -0.08% | 6.20% |
| Effective Tax Rate | - | - | - | - | - | 41.11% |
Source: S&P Capital IQ. Standard template.